Join
Live feed
·
PRReleasevia Quantisnow
Upstream Bio Inc. logo

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

ByQuantisnow·Wall Street's wire, on your screen.
UPB· Upstream Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UPB (Upstream Bio Inc.) and more on Quantisnow.